Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Seattle Genetics, Inc.
Scientific Title
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors